Bioray Pharmaceutical Co., Ltd.

This study is testing an experimental drug called BRY812 for women with advanced gynecologic cancers that have a specific marker called LIV-1 and have stopped responding to prior treatments. The main goal is to see if the drug can shrink tumors and to understand its safety. About…

This study is testing a new oral medication called BR2251 to see if it can safely lower high uric acid levels in people with gout. Researchers will compare three different doses of BR2251 against a standard gout medication over 12 weeks in 160 participants. The main goal is to fi…